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Abstract This Classic Article is a reprint of the original
work by Marshall R. Urist, A Morphogenetic Matrix for
Differentiation of Bone Tissue. An accompanying bio-
graphical sketch of Marshall R. Urist, MD is available at
DOI 10.1007/s11999-009-1067-4; a second Classic Article
is available at DOI 10.1007/s11999-009-1068-3; and a
third Classic Article is available at DOI 10.1007/s11999-
009-1069-2. The Classic Article is  1970 by Springer and
is reprinted with permission from Urist MR. A
morphogenetic matrix for differentiation of bone tissue.
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The development of bone is multiphasic, proceeding con-
currently from deposition of woven bone (histogenesis), to
resorption and reformation of an ossicle of lamellar bone
filled with bone marrow (morphogenesis). Recent experi-
mental works on differentiation of post-fetal mesenchymal
cells of muscle demonstrate the three requirements for
bone morphogenesis. The first is the cell intrinsic or
genetic blueprints, including competence, a state of unex-
pressed readiness to synthesize specialized cell products.
The second, is an extrinsic or extracellular substratum for
cell intercommunications and interactions. The third, is the
accessory supply complex which includes all the meta-
bolic, endocrine, nutritional and mineral requirements for
building specialized cell products. The first and third
requirements are now well defined in the physico-chemical
terms in modern textbooks of cell biology. The second, the
cell communication or extrinsic system is poorly undefined
and usually open to doubt. This lecture will present some
new evidence of the existence of local extrinsic require-
ments of post-fetal mesenchymal cells for bone
morphogenesis.
Mesenchymal cells differentiate into bone in the interior
of a block of bone matrix implanted in belly of a muscle
within a period of 2 to 3 weeks. The reaction occurs almost
invariably in mice, rats, guinea pigs and rabbits if the
matrix is prepared by decalcification in 6/10 normal HCl at
2C for not more than 3 or 4 days, and if denaturation and
gelatinization of the bone collagen is minimal [1–14]. After
rat bone matrix is decalcified, it can be preserved by
lyophilization and stored in sterile vials, for at least one
year with very little loss of its morphogenetic properties.
Within 10 to 15 days after implantation of bone matrix,
mesenchymal cells grow in from the surrounding muscle
into every available old vascular channel, proliferate, fuse,
and become multinucleated cells. Through the action of
multinucleated giant cells and some mononucleated forms,
the old matrix is resorbed and replaced by reticular cells
which appear to be the product of fission of multinucleated
cells and perivascular connective tissue cells of sprouting
capillaries. These reticular cells can be classified as
osteoprogenitor cells because they differentiate into oste-
oblasts and deposit bone on the walls of excavation
chambers in the interior of the implant. In some locations
deep in the implant, isolated from sprouting capillaries,
mesenchymal cells proliferate, aggregate and differentiate
directly into hyaline cartilage. Later the cartilage
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vascularizes, modulates and produces endochondral
deposits of new bone. The earliest deposits consist of
woven bone which are remodelled immediately after for-
mation. The remodelling process occurs in two directions,
centripetally to replace woven bone with hematopoietic
bone marrow and centripetally to replace woven bone with
lamellar bone. The process is an example of diverse means
to a common end which is, as previously stated, not simply
histogenesis but morphogenesis, a process of formation of
a spherical ossicle consisting of a cortex and a central
medulla filled with bone marrow.
The chemical components of bone matrix responsible
for its morphogenetic properties appear to be intimately
associated with the interfibrillar cross-links and weave
pattern of collagen fibers found in all calcified tissues.
Morphogenetic properties are displayed by intramuscular
implants of decalcified matrix prepared from enamel,
dentin, calcified cartilage, calcified placenta, urinary blad-
der epithelium. Lathyritic bone, although fully calcified, is
poorly cross-linked and readily solubilized and does not
possess morphogenetic properties following implantation
in muscle. The morphogenetic process is relatively easy to
quantitate, because the implanted matrix is ashless, and the
yield of new bone is proportional to the quantity of ash
following incineration at 300C. In general, the yield of
new bone is proportional to the mass of implanted matrix,
but there is a plateau in the quantity of new bone which is
determined by the number of mesenchymal cells available
for migration and proliferation.
While the proliferation and differentiation of mesen-
chymal cells is also dependent upon the development of the
vascular network for the transport of the accessory meta-
bolic nutritional factors, endothelial cells and intravascular
blood elements are not the source of the new cartilage or
bone cells. Implants of morphogenetic matrix and minced
muscle produce new cartilage and chondroosteoid even in
the interior of millipore chambers (pore size, .45l and a
thickness of 125l) which exclude capillaries. Recently, in
collaboration with NOGAMI [12], we are able to explant
small fragments of muscle in the medulla of segments of
diaphyseal decalcified bone matrix, and observe differen-
tiation of mesenchymal cells into cartilage in a chemically-
defined tissue culture medium within a period of nine days.
If the BGJ medium is supplemented with plasma, cartilage
cells hypertrophy, modulate and produce endochondral
bone. The intercellular matrix of cartilage calcifies and is
resorbed in tissue culture without the development of
capillary sprouts (Fig. 3). In the absence of the morpho-
genetic matrix in tissue culture, mesenchymal cells grow
out onto the flask in a monolayer and differentiate into
fibroblasts and produce only a network of collagen fibrils.
Denatured bone matrix similarly produces only fibrous
Fig. 1 Diagramatic illustration of sequence of events, time relationships, and changes in culture media in differentiation of cartilage in response
to a morphogenetic matrix in vitro.
Fig. 2 Photomicrograph showing new cartilage proliferating on the
surface of 0.6 N HCl decalcified bone matrix in BGJ culture medium
approximately 20 days after explantation. Hematoxylin eosin and
azure II.
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tissue. Thus, a morphogenetic matrix or inductive sub-
stratum appears to be an essential requirement of the
system. Prior to the use of the above described preparations
of bone morphogenetic matrix, tissue culture work on bone
was limited to development of embryonic cartilage models,
and surviving calvareal bone cells. No bone cell differen-
tiation de novo in tissue culture seems to have been
reported previously, presumably because a morphogenetic
matrix was unavailable.
Undemineralized bone matrix implanted in muscle fails to
produce more than a scanty deposit of new bone and never in
more than a few percent of trials. Surface-demineralized
lyophilized implants also produce small deposits, but the
yield is proportional to the mass of the demineralized frac-
tion of the implanted matrix. Particles of demineralized bone
matrix produce only a chronic inflammatory and massive
giant cell reaction, but pellets of particulate bone mineral
produce an encysted ossicle. Deamination or dinitropheno-
lation of the epsilon-amino groups, irradiation and other
physical agents which produce denaturation of the bone
collagen destroy the morphogenetic properties of the bone
matrix.
Species differences which are presently difficult to
explain, are an obstacle to the clinical use of morphogenetic
matrix as a substitute for a bone graft. Dogs, monkeys,
baboons, and human beings produce much lower yields of
new bone than rodents in intramuscular implants of bone
matrix; frogs and birds also produce only very small yields of
new bone by presently known methods of decalcification of
the morphogenetic cross-linked structure of the bone matrix.
Dentin matrix, which is highly permeable to demineralizing
solutions and more highly cross-linked than bone matrix,
produces a high yield of new bone even in dogs. The rela-
tionship between the insoluble cross-linked structure, the
calcification initiator, and morphogenetic properties of the
implanted matrix seems to hold the key to the solution of
the problem of osteogenesis as we see it now [11].
Differences in osteogenetic competence, a state of
unexpressed readiness of mesenchymal cell population to
differentiate into bone cells, indicates that there are no
wholly undifferentiated cells in the body. Implants of bone
matrix in thyroid, thymus, spleen, liver, and kidney reveal
that the mesenchyma of these organs are osteogenetically
incompetent. Implants of bone matrix into subcutaneous
tissue, brain, spinal cord, i.v. disc, muscle, cartilage bone,
bone marrow, tendon and peritoneum and many visceral
organ connective tissue capsules display osteogenetic
competence [10]. The cardinal question—which physico-
chemical component or components of the matrix activate
osteogenetic competence, and how the property is trans-
mitted from one mesenchymal cell generation to
another—is presently unanswerable. Whatever the mor-
phogenetic property may be, its effects are so rapidly
transferred from matrix to mesenchyma that HUGGINS and
associate [3] report a 10-fold rise in tissue alkaline phos-
phatase activity, measured by accurate methods within
5 days after decalcified dentin is implanted subcutaneously
in rats.
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Fig. 3 Photomicrograph showing hypertrophic cartilage developed
and calcified in vitro 30 days after explantation of endomysial
mesenchymal cells in a cylinder of bone matrix in BGJ culture
medium. Hematoxylin eosin and von Kossa stain. Arrowhead
indicates direction of ingrowth of mesenchyma.
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